Pulse Biosciences Earnings
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.35
Pulse Biosciences earnings summary
Pulse Biosciences is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.35. In its most recent report on Aug 6, 2026 (Q2 2026), PLSE posted EPS of $-0.36. Revenue for the quarter was $434,000.
Across the last 16 reports, PLSE shares moved an average of 11.0% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
PLSE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.36 | — | +5.0% |
| May 14, 2026 | — | $-0.27 | — | +5.5% |
| Feb 19, 2026 | — | $-0.26 | — | -12.6% |
| Nov 5, 2025 | — | $-0.29 | — | -6.9% |
| Aug 12, 2025 | — | $-0.28 | — | +5.5% |
| May 8, 2025 | — | $-0.25 | — | +0.7% |
| Mar 31, 2025 | — | $-0.33 | — | +6.4% |
| Oct 30, 2024 | — | $-0.21 | — | +36.5% |
| Aug 19, 2024 | — | $-0.20 | — | -13.2% |
| May 7, 2024 | — | $-0.18 | — | +4.8% |
| Mar 28, 2024 | — | $-0.18 | — | -13.1% |
| Nov 13, 2023 | — | $-0.19 | — | +18.8% |
| Aug 10, 2023 | — | $-0.22 | — | +16.1% |
| May 11, 2023 | — | $-0.26 | — | -15.9% |
| Mar 31, 2023 | — | $-0.21 | — | +9.2% |
| Nov 10, 2022 | — | $-0.49 | — | -5.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.